Incidence, mortality, and national costs of hospital admissions for potentially preventable infections in patients with rheumatoid arthritis
- 12 July 2021
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (12) , 4845-4851
Abstract
Introduction Rheumatoid arthritis (RA) patients have high infection rates. Streptococcus pneumoniae, herpes zoster (HZV), and influenza are common and potentially preventable causes of morbidity and mortality. Vaccinations have been shown to reduce the rates of these infections. In this study, we aim to determine incidence, mortality, and national costs of hospital admissions for Streptococcus pneumoniae, HZV, and influenza infections in patients with RA. Methods We conducted a retrospective analysis of the adult RA hospitalizations in 2016 from the National Inpatient Sample database. We limited the RA cases to hospitalizations with a principal discharge diagnosis of S. pneumoniae, HZV, and influenza infections. The total number of discharges, age, length of stay, mortality, and hospital charges were recorded. Results In 2016, 552,230 adult hospitalizations had either a primary or secondary diagnosis of RA. Among this group, there were 1120 hospitalizations for influenza, 590 hospitalizations for herpes zoster, and 785 hospitalizations for S. pneumoniae. These infections constituted 0.5% of RA hospitalizations and were a more common cause of hospitalizations when compared to non-RA hospitalizations. Aggregate annual national hospital charges reached $124 million and an aggregate annual LOS of 13,750 days. Conclusion Infections, such as influenza, HZV, and S. pneumoniae, remain a common cause of inpatient morbidity and mortality among RA patients. Additionally, the economic burden of these infections is significant. Universal vaccination programs in RA patients, as well as other interventions aiming to improve quality of care of this susceptible population, should be further studied to reduce hospitalizations, cost, morbidity, and mortality. Key Points • Streptococcus pneumoniae, herpes zoster, and influenza infections remain an important preventable cause of hospitalizations among RA patients and carry significant economic burden.Keywords
This publication has 34 references indexed in Scilit:
- Vaccinations for Rheumatoid ArthritisCurrent Rheumatology Reports, 2014
- The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatmentRheumatology, 2012
- Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort studyBMC Musculoskeletal Disorders, 2012
- Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated DiseasesJAMA, 2012
- The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analysesArthritis Research & Therapy, 2011
- Vaccination survey in patients with rheumatoid arthritis: a cross-sectional studyRheumatology International, 2011
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus ErythematosusClinical Infectious Diseases, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Pyarthrosis in patients with rheumatoid arthritis: A report of 13 cases and a review of the literature from the past 40 yearsThe American Journal of Medicine, 1990